36134370|t|Targeting cell surface glycans with lectin-coated fluorescent nanodiamonds.
36134370|a|Glycosylation is arguably the most important functional post-translational modification in brain cells and abnormal cell surface glycan expression has been associated with neurological diseases and brain cancers. In this study we developed a novel method for uptake of fluorescent nanodiamonds (FND), carbon-based nanoparticles with low toxicity and easily modifiable surfaces, into brain cell subtypes by targeting their glycan receptors with carbohydrate-binding lectins. Lectins facilitated uptake of 120 nm FND with nitrogen-vacancy centers in three types of brain cells - U87-MG astrocytes, PC12 neurons and BV-2 microglia cells. The nanodiamond/lectin complexes used in this study target glycans that have been described to be altered in brain diseases including sialic acid glycans via wheat (Triticum aestivum) germ agglutinin (WGA), high mannose glycans via tomato (Lycopersicon esculentum) lectin (TL) and core fucosylated glycans via Aleuria aurantia lectin (AAL). The lectin conjugated nanodiamonds were taken up differently by the various brain cell types with fucose binding AAL/FNDs taken up preferentially by glioblastoma phenotype astrocyte cells (U87-MG), sialic acid binding WGA/FNDs by neuronal phenotype cells (PC12) and high mannose binding TL/FNDs by microglial cells (BV-2). With increasing recognition of glycans having a role in many diseases, the lectin bioconjugated nanodiamonds developed here are well suited for further investigation into theranostic applications.
36134370	23	30	glycans	Chemical	MESH:D011134
36134370	205	211	glycan	Chemical	MESH:D011134
36134370	248	269	neurological diseases	Disease	MESH:D020271
36134370	274	287	brain cancers	Disease	MESH:D001932
36134370	377	383	carbon	Chemical	MESH:D002244
36134370	413	421	toxicity	Disease	MESH:D064420
36134370	596	604	nitrogen	Chemical	MESH:D009584
36134370	653	659	U87-MG	CellLine	CVCL:0022
36134370	672	684	PC12 neurons	CellLine	CVCL:U378
36134370	689	693	BV-2	CellLine	CVCL:0182
36134370	770	777	glycans	Chemical	MESH:D011134
36134370	820	834	brain diseases	Disease	MESH:D001927
36134370	845	864	sialic acid glycans	Chemical	-
36134370	869	910	wheat (Triticum aestivum) germ agglutinin	Species	
36134370	912	915	WGA	Species	
36134370	923	930	mannose	Chemical	MESH:D008358
36134370	931	938	glycans	Chemical	MESH:D011134
36134370	943	982	tomato (Lycopersicon esculentum) lectin	Species	
36134370	984	986	TL	Species	1081372
36134370	1009	1016	glycans	Chemical	MESH:D011134
36134370	1021	1044	Aleuria aurantia lectin	Species	
36134370	1046	1049	AAL	Species	
36134370	1150	1156	fucose	Chemical	MESH:D005643
36134370	1165	1168	AAL	Species	
36134370	1201	1213	glioblastoma	Disease	MESH:D005909
36134370	1241	1247	U87-MG	CellLine	CVCL:0022
36134370	1250	1261	sialic acid	Chemical	MESH:D019158
36134370	1270	1273	WGA	Species	
36134370	1308	1312	PC12	CellLine	CVCL:0481
36134370	1323	1330	mannose	Chemical	MESH:D008358
36134370	1339	1341	TL	Species	1081372
36134370	1368	1372	BV-2	CellLine	CVCL:0182
36134370	1406	1413	glycans	Chemical	MESH:D011134
36134370	Association	MESH:D011134	MESH:D020271
36134370	Association	MESH:D011134	MESH:D001927
36134370	Association	MESH:D008358	MESH:D001927
36134370	Association	MESH:D011134	MESH:D001932

